Voraxaze Injection, Powder, For Solution
Product Images NDC 50633-210

2 FDA label images from Btg International Inc. · Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 2 technical images submitted to the FDA as part of the official labeling for Voraxaze (NDC 50633-210). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Btg International Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Package Label (Principal Display Panel)

Package Label (Principal Display Panel)
Label for Voraxaze (glucarpidase) injection, powder for solution, showing 1000 units per vial for intravenous use. The label includes NDC 50633-210-11, manufacturer BTG International Inc., Brentwood, TN, and usage instructions to see package insert for dosage and other information. It is for single-use and Rx only.*
FDA Label Image

Package Label (Principal Display Panel)

Package Label (Principal Display Panel)
Voraxaze 1000 Units/vial injection powder for solution label by BTG International Inc. The label states the product contains glucarpidase for intravenous injection, single vial presentation, stored at 2° to 8°C. It includes details about ingredients, packaging, lot, and expiration placeholders, along with manufacturer and distributor information and barcodes.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.